Spontaneous Mutations in the Human Cmv Hla Class I Homologue Ul18 Affect Its Binding to the Inhibitory Receptor Lir-1/Ilt2/Cd85j.
From: Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden. cristina.cerboni@mtc.ki.se
European journal of immunology
- Publish Date: Mar 2006
- ISSN: 0014-2980
- Volume: 36
- Issue: 3
- Pages: 732-41
- Medium: Print
- Language: English
- Citation (JAMA): Cerboni Cristina, Achour Adnane, Wärnmark Anette, et al. Spontaneous Mutations in the Human Cmv Hla Class I Homologue Ul18 Affect Its Binding to the Inhibitory Receptor Lir-1/Ilt2/Cd85j.. Eur. J. Immunol. Mar 2006;36:732-41
Abstract
Human cytomegalovirus (HCMV) down-regulates cell surface expression of HLA class I molecules (HLA-I). UL18, an HCMV-encoded HLA-I homologue, has been proposed to protect virus-infected cells against NK cell recognition by engaging the inhibitory receptor leukocyte Ig-like receptor (LIR)-1, which also binds a broad spectrum of HLA-I alleles, including HLA-G1. Because genetic and biological differences exist among HCMV strains, we characterized laboratory (AD169) and clinical (4636, 13B, 109B) strain-derived UL18 proteins. Compared to the known AD169-derived UL18, mutations were found in clinical strain-derived UL18. They were clustered in the alpha3 domain (13B), previously shown to be critical for LIR-1 binding, or in the alpha1 domain (4636). Iotan cytotoxicity assays, pretreatment of LIR-1+ NKL with soluble 4636-UL18 completely abolished LIR-1-dependent protection from NK lysis, conferred by the expression of HLA-G1 on target cells (721.221-HLA-G1+). Similarly, flow cytometry, Biacore and ELISA experiments showed 4636-UL18 and 13B-UL18 to have the strongest binding capacity to LIR-1. Our results suggest the importance of two independent UL18 regions for LIR-1 binding, one localized on the tip of the alpha3 domain, and another composed of two loops that emerge from the alpha1 domain. Strain variations in these domains may result in different UL18-mediated effects on LIR-1+ cells during the course of HCMV infection.
Mesh Headings (Keywords): Amino Acid Substitution, Antigens, CD, Capsid Proteins, Cells, Cultured, Cytomegalovirus, Cytomegalovirus Infections, HLA Antigens, Histocompatibility Antigens Class I, Humans, Immunity, Cellular, Killer Cells, Natural, Point Mutation, Protein Binding, Protein Structure, Tertiary, Receptors, Immunologic, Species Specificity
Check for Full Text / PubMed Unique Identifier (PMID): 16479538
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.